Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Friday, April 19, 2024 | Back issues
Courthouse News Service Courthouse News Service

Securities

OAKLAND, Calif. - Directors sold Celera Corp. to Quest Diagnostics for an inadequate $8 a share or $680 million - actually $236 million after subtracting cash on hand and tax credits - and Credit Suisse aided and abetted them, investors claim in a federal securities fraud complaint.

Categories / Uncategorized

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.

Loading...